Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Affinity Asset Advisors, LLC reported a 7.83% stake in Karyopharm Therapeutics Inc. (Schedule 13G)
Event Apr 3, 2025 · Filed Apr 10, 2025
Affinity Asset Advisors, LLC reported a 7.83% stake in Karyopharm Therapeutics Inc., 664,224 shares, as a passive investor on Apr 3, 2025. Filed Apr 10, 2025 (Schedule 13G).
- Stake
- 7.83%
- Shares
- 664,224
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Affinity Healthcare Fund, LP | 7.83% | 664,224 |
| Affinity Asset Advisors, LLC | 7.83% | 664,224 |
Source
Related
- Karyopharm Therapeutics Inc.
- Affinity Asset Advisors, LLC
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · Affinity Asset Advisors, LLC · May 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Jan 29, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026